Publication | Closed Access

Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer’s Aβ1–42 fibril formation in vitro

Aβ1–42 Fibril FormationMedicinal ChemistryNeurodegenerative DiseasesAlzheimer's DiseaseFerrocenoyl PentapeptideBiochemistryMedicineNatural SciencesProtein MisfoldingAlzheimer ’NeuroprotectionPharmacologyPharmaceutical ChemistryDrug Discovery